Trending...
- DimHum Launches Revolutionary CrowdShipping Service
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
PHILADELPHIA, Dec. 7, 2023 /PRNewswire/ -- Berger Montague PC is currently investigating potential violations of the federal securities laws on behalf of shareholders of Eagle Pharmaceuticals, Inc. ("Eagle") (NASDAQ: EGRX).
Eagle is a pharmaceutical company focused on developing treatments for diseases of the central nervous system or metabolic critical care, as well as oncology.
On November 9, 2023, Eagle disclosed that it would not be able to timely file its quarterly report for the second quarter of 2023 because it required additional time to complete its review of potential adjustments relating to the reporting of sales of PEMFEXY.
On this news, the price of Eagle shares fell $4.16 per share, or 30%, to close at $9.54 per share on November 9, 2023.
Then, on November 29, 2023, Eagle disclosed in a filing with the U.S. Securities and Exchange Commission that Eagle's President and Chief Executive Officer, Scott Tarriff, was resigning and that the board of directors accepted the resignation "[a]fter consideration of various alternatives, including termination with or without cause."
More on The PennZone
On this news, Eagle's share price fell $2.55, or 31%, to close at $5.68 per share on November 29, 2023.
If you are an Eagle investor and would like to learn more about our investigation, please contact Berger Montague: James Maro at [email protected] or (267) 637-3176, or Andrew Abramowitz at [email protected] or (215) 875-3015 or CLICK HERE.
Whistleblowers: Anyone with non-public information regarding Eagle is encouraged to confidentially assist Berger Montague's investigation or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us.
More on The PennZone
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
Contacts:
James Maro, Senior Counsel
Berger Montague
(267) 637-3176
[email protected]
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
SOURCE Berger Montague
Eagle is a pharmaceutical company focused on developing treatments for diseases of the central nervous system or metabolic critical care, as well as oncology.
On November 9, 2023, Eagle disclosed that it would not be able to timely file its quarterly report for the second quarter of 2023 because it required additional time to complete its review of potential adjustments relating to the reporting of sales of PEMFEXY.
On this news, the price of Eagle shares fell $4.16 per share, or 30%, to close at $9.54 per share on November 9, 2023.
Then, on November 29, 2023, Eagle disclosed in a filing with the U.S. Securities and Exchange Commission that Eagle's President and Chief Executive Officer, Scott Tarriff, was resigning and that the board of directors accepted the resignation "[a]fter consideration of various alternatives, including termination with or without cause."
More on The PennZone
- e4health Earns 2025-2026 Great Place To Work Certification™ for Fourth Consecutive Year
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
- NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
- Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
- Palmer Lake Wine Festival To Build Bridges in Small Mountain Community, Highlight Local Businesses
On this news, Eagle's share price fell $2.55, or 31%, to close at $5.68 per share on November 29, 2023.
If you are an Eagle investor and would like to learn more about our investigation, please contact Berger Montague: James Maro at [email protected] or (267) 637-3176, or Andrew Abramowitz at [email protected] or (215) 875-3015 or CLICK HERE.
Whistleblowers: Anyone with non-public information regarding Eagle is encouraged to confidentially assist Berger Montague's investigation or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us.
More on The PennZone
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
Contacts:
James Maro, Senior Counsel
Berger Montague
(267) 637-3176
[email protected]
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
SOURCE Berger Montague
Filed Under: Business
0 Comments
Latest on The PennZone
- DICK'S Sporting Goods Announces DICK'S Deal Days, a Four-Day Summer Savings Event
- AI Innovation Dual-Strategy Business Model Focused on Real Estate Development for Strategic Expansion: OFA Group, (N A S D A Q: OFAL)
- Construcción del Corredor Norte–Sur (NSC) de Singapur
- New Report: Slip and Fall Accidents Rank as the Leading Cause of Construction Site Fatalities
- Get Your Cowboy Boots On! Causeway Country BBQ Music Festival Kicks Off September 12–14 in Ft. Pierce
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
- DimHum Launches Revolutionary CrowdShipping Service
- Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- Berger Montague Investigates Securities Class Action Against Hims & Hers Health Inc. (NYSE: HIMS)
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- #ChipInChipAway at Hunger Taking Place on July 10th, 2025
- Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
- Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
- Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT